retatrutide side effects effects: what the trials show and how to manage them Retatrutide Helped Adults With Diabetes

New research published in JACC , the flagship journal of the American College of Cardiology, and presented just last month at the 2024 American Heart Association Scientific Sessions revealed that GLP-1 drugs, including semaglutide, offer cardiovascular benefits beyond weight loss

This may include medical history, treatment records, and evidence of other treatments youve tried

What happened to Rite Aid

Phase 2 clinical trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) demonstrated substantial weight reduction in participants with obesity

The launch of Lilly's oral GLP-1 pill called orforglipron is expected to expand the addressable market